ARES Group Acquires Cardiology Activities of Monza Hospital; Forms MONZA-ARES Group
December 14, 2023
ARES Group, a Highlander Partners portfolio company, has completed the acquisition of the cardiology activities of Monza Hospital in Bucharest from Policlinico di Monza and will operate the hospital's cardiovascular surgery and interventional cardiology departments. Concurrently, Brain Hospital will take over Monza's neurosurgery, ENT, orthopedics and other surgical departments, and the combined cardiology platform will operate under the newly formed MONZA-ARES Group to expand private cardiology services across Romania.
- Buyers
- ARES Group, Brain Hospital, Highlander Partners
- Targets
- Monza Hospital (cardiology activities)
- Sellers
- Policlinico di Monza
- Platforms
- ARES Group
- Industry
- Healthcare Services
- Location
- Bucharest, Romania
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
ARES (Highlander Partners Portfolio Company) Acquires Cardiomed Cluj
December 22, 2021
Healthcare Services
ARES, a leading Romanian interventional cardiology operator controlled by Highlander Partners, has acquired Cardiomed Cluj to create an integrated cardiology platform in Cluj-Napoca. The deal brings Cardiomed’s large outpatient and imaging capabilities into the ARES network to expand early diagnosis, imaging and interventional cardiology services; Cardiomed founder Dr. Carmen Mureșan will continue to lead the business.
-
Highlander Partners Acquires Majority Stake in Ares (Centrele de Excelență Ares)
July 2, 2019
Healthcare Services
Highlander Partners L.P. acquired a majority stake in Ares Group (Centrele de Excelență Ares), the leading private interventional cardiology provider in Romania. Highlander will partner with founders Oren Iancovici and Iulian Plescan to expand capacity and open new facilities across Romania to increase access to interventional cardiology and interventional radiology services.
-
ARCHIMED (MED Platform I) Acquires Majority Stake in CARSO
December 16, 2021
Healthcare Services
Transatlantic healthcare private equity firm ARCHIMED, via its MED Platform I fund and in partnership with CAPZA Expansion and Siparex, has acquired a majority stake in Lyon-based CARSO, a leader in purity and analytical testing for pharma, healthcare, environmental and food sectors. The deal (debt provided by Tikehau Capital and several banks) will support CARSO's internationalization and service-range expansion as the group aims to more than double current annual revenues (above €200 million).
-
Miura Partners Backs Saesco Medical; Saesco Acquires Cardiolink
May 9, 2025
Medical Devices
Miura Partners has invested in Saesco Medical via a capital increase to support the company's international growth and consolidation across Europe. As part of the transaction Saesco — now backed by Miura — has acquired Cardiolink, strengthening Saesco's product portfolio and presence in the Iberian public hospital network; the combined group will generate over €50m in revenue.
-
Eurazeo to Acquire Eres Group Stake from IK Partners
April 22, 2024
Financial Services
Eurazeo has signed an agreement to acquire the stake in French fintech Eres Group from IK Partners' IK VIII Fund; financial terms were not disclosed and the transaction is subject to regulatory approvals. Eres, headquartered in Paris, is a leading provider of employee profit-sharing, retirement schemes and asset management with approximately €6.7 billion in assets under management and a distribution network of over 6,600 distributors.
-
ARCHIMED Acquires Majority Stake in Cardioline
November 17, 2021
Medical Devices
Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.